Dramatic clinical response following dabrafenib and trametinib therapy in a heavily pretreated low grade serous ovarian carcinoma patient with a BRAF V600E mutation

Low grade serous ovarian cancer (LGSOC) is a slowly growing, relatively chemoresistant neoplasm that is associated with a more favorable prognosis, especially compared to the disease's high-grade serous counterpart. We recount a case involving a 47-year-old, heavily pretreated LGSOC patient who...

Descripción completa

Detalles Bibliográficos
Autores principales: Mendivil, Alberto A., Tung, Paul K., Bohart, Randy, Bechtol, Karen, Goldstein, Bram H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141637/
https://www.ncbi.nlm.nih.gov/pubmed/30246138
http://dx.doi.org/10.1016/j.gore.2018.09.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141637/
https://www.ncbi.nlm.nih.gov/pubmed/30246138
http://dx.doi.org/10.1016/j.gore.2018.09.002

Ejemplares similares